Steven Cohen’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Steven Cohen's VIR Position: Q3 2026 in Review
Steven Cohen increased its Vir Biotechnology (VIR) stake by 20% in Q3 2026, buying an estimated $11.1M and bringing the position to 6,772,292 shares worth $75.7M. The position accounts for 0.08% of the portfolio, ranked #291.
Steven Cohen first reported a position in VIR in Q3 2021 and has held it in 15 quarters since. The position peaked at $86M in Q4 2021. 263 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Steven Cohen held 6,772,292 shares of Vir Biotechnology worth $75.7M as of Q3 2026.
- Steven Cohen bought 1,105,471 Vir Biotechnology shares in Q3 2026, an estimated $11.1M.
- Vir Biotechnology made up 0.08% of Steven Cohen's portfolio in Q3 2026, its #291 holding.
- Steven Cohen first reported a position in Vir Biotechnology in Q3 2021 and has held it in 15 quarters since.
- Steven Cohen's Vir Biotechnology position peaked at $86M in Q4 2021.
- 263 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.